Humacyte, Inc. (HUMA) Operating cash flow 2020–2025
Humacyte, Inc. (HUMA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$105.0MFY2025 · since FY2020: -$55.6M → -$105.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$105.0M | -7.1% |
| FY2024 | -$98.1M | -33.9% |
| FY2023 | -$73.3M | -3.1% |
| FY2022 | -$71.1M | +12.4% |
| FY2021 | -$81.2M | -46.1% |
| FY2020 | -$55.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HUMA financial trends
HUMA RevenueHUMA Net incomeHUMA Net marginHUMA Gross profitHUMA Gross marginHUMA Operating incomeHUMA Operating marginHUMA Free cash flowHUMA Capital expendituresHUMA Return on equityHUMA Stock buybacksHUMA Dividends paidHUMA Total assetsHUMA Total liabilitiesHUMA Shareholders’ equityHUMA overview →